Denali Therapeutics Inc.'s stock remains stable despite trial setback in ALS. BLA filing for MPS II treatment on track. Click ...

Announcing a new publication for Acta Materia Medica journal. Complex biological mechanisms and unidentified therapeutic targets for amyotrophic lateral sclerosis (ALS) significantly hinder the develo ...

Alchemab Therapeutics (Alchemab), a biopharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, today announces it has entered a ...

When he was 25, he learned that he had multiple sclerosis. He coped with the disease throughout a long career at several ...

It can take twice as long for people to receive an amyotrophic lateral sclerosis (ALS) diagnosis if they are seen in a general neurology clinic compared to a specialist clinic, […] ...

Keith Williams has seen the growth of opportunity and inclusion in the disabled community for over four decades, but as he ...

"The initial presentation typically includes dementia and neurological symptoms such as ataxia, myoclonus, and gait abnormalities as well as behavioral changes," Cetin and co-authors wrote. Sporadic ...

After being diagnosed with A.L.S. in 2022, Brooke Eby could have turned inward. Instead, she opened up — and found a fan base online.

Ractigen Therapeutics begins patient dosing in phase I trial of RAG-17 in SOD1-ALS: Nantong, China Friday, December 27, 2024, 12:00 Hrs [IST] Ractigen Therapeutics, a clinical-sta ...

Think muscle twitches are harmless? Think again. Discover the hidden health risks and learn when to take action.

Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications ...